28 Jul BioSpace: Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America
An article in BioSpace on Atomo’s agreement with US-based Access Bio Inc. for COVID-19 antibody testing in North America.